Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

OMADA HEALTH ($OMDA) Releases Q2 2026 Earnings, Stock Rises

None

OMADA HEALTH ($OMDA) posted quarterly earnings results for Q2 2026 on Thursday, August 6th. The company reported earnings of $0.15 per share, beating estimates of -$0.02 by $0.17. The company also reported revenue of $87,840,000, beating estimates of $81,793,708 by $6,046,292.

Stock price change since market close: +1.54%

You can see Quiver Quantitative's $OMDA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

EARLY ACCESS
Receive OMDA Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

OMADA HEALTH Insider Trading Activity

OMDA Insider Trades

OMADA HEALTH insiders have traded $OMDA stock on the open market 34 times in the past 6 months. Of those trades, 0 have been purchases and 34 have been sales.

Here’s a breakdown of recent trading of $OMDA stock by insiders over the last 6 months:

  • STEVEN L. COOK (Chief Financial Officer) has made 0 purchases and 14 sales selling 134,334 shares for an estimated $2,810,523.
  • SEAN P. DUFFY (Chief Executive Officer) has made 0 purchases and 10 sales selling 75,111 shares for an estimated $1,511,333.
  • CRAIG GRACEY (Chief Accounting Officer) has made 0 purchases and 8 sales selling 17,310 shares for an estimated $331,186.
  • WEI-LI SHAO (President) has made 0 purchases and 2 sales selling 7,418 shares for an estimated $115,063.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

OMADA HEALTH Hedge Fund Activity

We have seen 80 institutional investors add shares of OMADA HEALTH stock to their portfolio, and 69 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

OMADA HEALTH Analyst Ratings

Wall Street analysts have issued reports on $OMDA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Needham issued a "Buy" rating on 05/08/2026

To track analyst ratings and price targets for OMADA HEALTH, check out Quiver Quantitative's $OMDA forecast page.

OMADA HEALTH Price Targets

Multiple analysts have issued price targets for $OMDA recently. We have seen 10 analysts offer price targets for $OMDA in the last 6 months, with a median target of $21.5.

Here are some recent targets:

  • Craig Hettenbach from Morgan Stanley set a target price of $30.0 on 06/22/2026
  • Ryan MacDonald from Needham set a target price of $28.0 on 05/08/2026
  • Elizabeth Anderson from Evercore ISI Group set a target price of $20.0 on 05/08/2026
  • Stan Berenshteyn from Wells Fargo set a target price of $18.0 on 05/08/2026
  • Saket Kalia from Barclays set a target price of $20.0 on 05/08/2026
  • Constantine Davides from Citizens set a target price of $21.0 on 05/08/2026
  • David Roman from Goldman Sachs set a target price of $23.0 on 04/09/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles